Immunomeedics

Immunomedics' Triple-Negative Breast Cancer Trial Halted Early Due to Compelling Efficacy
BioSpace
Tue, 04/7/20 - 10:10 am
Immunomeedics
sacituzumab govitecan
clinical trials
breast cancer
triple negative breast cancer